Evidence map›Paper›PMID 26299965›Full record

ArticleCell reports2015

Mitotic Stress Is an Integral Part of the Oncogene-Induced Senescence Program that Promotes Multinucleation and Cell Cycle Arrest.

Dina Dikovskaya, John J Cole, Susan M Mason, Colin Nixon, Saadia A Karim, Lynn McGarry, William Clark, Rachael N Hewitt, Morgan A Sammons, Jiajun Zhu and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Article
  3. Polyploidy and Senescence of Cancer Cells: Impact of Cell Fusion.Advances in experimental medicine and biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Abnormal expression ofBlood research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Dina DikovskayaInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK. Electronic address: ddikovskaya@gmail.com.
John J ColeInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK.
Susan M MasonBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Colin NixonBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Saadia A KarimBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Lynn McGarryBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
William ClarkBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Rachael N HewittInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK.
Morgan A SammonsDepartment of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6058, USA.
Jiajun ZhuDepartment of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6058, USA.
Dimitris AthineosBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Joshua D G LeachSchool of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK.
Francesco MarchesiSchool of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK.
John van TuynInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK.
Stephen W TaitInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK.
Claire BrockInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK.
Jennifer P MortonBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Hong WuFox Chase Cancer Center, Philadelphia, PA 19111-2497, USA.
Shelley L BergerDepartment of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6058, USA.
Karen BlythBeatson Institute for Cancer Research, Glasgow G61 1BD, UK.
Peter D AdamsInstitute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, UK. Electronic address: p.adams@beatson.gla.ac.uk.
Cancer Research UK Scotland Institute · GBUniversity of Glasgow · GBUniversity of Pennsylvania · USFox Chase Cancer Center · US

Funding

STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITYP01AG031862 · NIA · WISTAR INSTITUTE · PI GARCIA, BENJAMIN A · 2008 to 2022
$28.3M
Cancer Research UK 16566Cancer Research UK 20409Cancer Research UK C10652/A16566Cancer Research UK C596/A17196Cancer Research UK C596/A18076Medical Research Council BB/K017223/1Medical Research Council G1100054NIA NIH HHS P01 AG031862
6 · The paper itself

Abstract

Oncogene-induced senescence (OIS) is a tumor suppression mechanism that blocks cell proliferation in response to oncogenic signaling. OIS is frequently accompanied by multinucleation; however, the origin of this is unknown. Here, we show that multinucleate OIS cells originate mostly from failed mitosis. Prior to senescence, mutant H-RasV12 activation in primary human fibroblasts compromised mitosis, concordant with abnormal expression of mitotic genes functionally linked to the observed mitotic spindle and chromatin defects. Simultaneously, H-RasV12 activation enhanced survival of cells with damaged mitoses, culminating in extended mitotic arrest and aberrant exit from mitosis via mitotic slippage. ERK-dependent transcriptional upregulation of Mcl1 was, at least in part, responsible for enhanced survival and slippage of cells with mitotic defects. Importantly, mitotic slippage and oncogene signaling cooperatively induced senescence and key senescence effectors p21 and p16. In summary, activated Ras coordinately triggers mitotic disruption and enhanced cell survival to promote formation of multinucleate senescent cells.

Indexed as

Cellular SenescenceMitosisCell LineCells, CulturedGiant CellsHumansMutationMyeloid Cell Leukemia Sequence 1 Proteinras ProteinsMCL1 protein, humanMyeloid Cell Leukemia Sequence 1 Proteinras Proteins

Identifiers

PMID26299965
PMCPMC4562906
OpenAlexW1648206179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.